Skip to main content

Pamela J Lein

NIH Rank #2835
  • Program Leader
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1931492Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • VETERINARY SCIENCES
  • Public Health

NIH Funding · FY2024

Linked Award Amount
$2.9M
Full award amounts, FY2024
Award Records
9
Records listing this PI
Award-Linked Rank
#2,835
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Pamela J Lein. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Pamela J Lein as a PI. Multi-PI records show the full award amount for context.

  • 4R01AG074709-02R01
    Traffic-related air pollution exacerbates AD-relevant phenotypes in a genetically susceptible rat model via neuroinflammatory mechanism(s)
    $768.9K
    award amount
  • 5R01ES031098-05R01
    PCB-mediated dysbiosis of the gut microbiome: A missing link in PCB-mediated neurodevelopmental disorders?
    $619.2K
    award amount
  • 5R01ES014901-13R01
    Molecular and Cellular Basis of PCB Developmental Neurotoxicity
    $611.1K
    award amount
  • 5U54NS127758-03U54
    UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate Intoxication
    $514.8K
    award amount
  • 3R01ES014901-13S1R01
    Diversity Supplement to Molecular and Cellular Basis of PCB Developmental Neurotoxicity
    $97.4K
    award amount
  • 3U54NS127758-03S1U54
    UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate Intoxication
    $88.5K
    award amount
  • 3U54NS127758-03S2U54
    UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate Intoxication
    $88.5K
    award amount
  • 3R01AG074709-02S1R01
    Diversity Supplement toTraffic-related air pollution exacerbates AD-relevant phenotypes in a genetically susceptible rat model via neuroinflammatory mechanism(s)
    $71.4K
    award amount
  • 3R01ES014901-13S2R01
    Diversity Supplement to Molecular and Cellular Basis of PCB Developmental Neurotoxicity (Mendieta)
    $21.6K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Pamela J Lein as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of California at Davis
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2835
  6. 2024
    Entered Top 25% Nationally
    Ranked #2835
  7. 2025
    $5M Cumulative Funding
  8. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  9. 2025
    R01 Grant Holder
  10. 2025
    Program/Center Grant Leader
  11. 2026
    $10M Cumulative Funding
  12. 2026
    Entered Top 10% Nationally
    Ranked #629
  13. 2026
    Entered Top 5% Nationally
    Ranked #629